ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results

Got story updates? Submit your updates here. ›

ONWARD Medical N.V., the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, announced that it will report its Full-Year 2025 Financial Results and host a webcast to provide a comprehensive business update on March 31, 2026.

Why it matters

ONWARD Medical is at the forefront of developing innovative neurotechnology solutions to help people with spinal cord injuries and other movement disabilities regain mobility and independence. This webcast will provide investors and the public with an important update on the company's progress and future plans.

The details

The webcast will be presented by CEO Dave Marver and held at 2:00 p.m. CEST / 08:00 a.m. ET. ONWARD Medical has been awarded 10 Breakthrough Device Designations from the FDA for its proprietary ARC Therapy. The company's ARC-EX System is cleared for commercial sale in the US and Europe, and it is also developing an investigational implantable system called ARC-IM that can be paired with a brain-computer interface and artificial intelligence.

• The webcast will be held on March 31, 2026.
• ONWARD Medical reported its Full-Year 2025 Financial Results.

What’s next

Investors and the public can register to join the webcast using the provided link.